All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Fresenius pounces on bank appetite for €1.6bn delayed draw

German healthcare group Fresenius (Ba1/BB+/BB+) is seeking to take advantage of what it sees as "favourable financing conditions" in the bank market to refinance its term loan ‘A’ and revolving credit facility due in September 2013.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree